Bupivacaine only is one of 246 small molecule programs targeting Hemorrhoid. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
242 competitors in Efficacy and Safety
Rinvoq
Savaysa
Platinol
Rapamune
Rilutek
Kineret
UPLIZNA
Bupivacaine only
Becotatug Vedotin
Apatinib Mesylate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details